Cognex (CGNX) shareholder files Form 144 to sell 177,052 shares on NASDAQ

Rhea-AI Filing Summary

Cognex Corporation shareholder files notice to sell restricted stock. A holder of Cognex common shares filed a Form 144 indicating an intention to sell 177,052 common shares through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $10,300,974.15 and 165,707,920 shares outstanding.

The shares relate to options granted on February 21, 2017 and February 20, 2024, which were acquired and paid in cash on February 12, 2026. Form 144 is a required notice before certain affiliates or large holders sell restricted or control securities.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	177052	10300974.15	165707920	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Option Granted - 02/21/2017	Issuer			173296	02/12/2026	Cash
Common	02/12/2026	Option Granted - 02/20/2024	Issuer			3756	02/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CGNX Form 144 filing indicate?

The Form 144 shows a Cognex common shareholder intends to sell 177,052 shares on NASDAQ. The planned sale has an aggregate market value of $10,300,974.15 and reflects a required notice for disposing of restricted or control securities.

How many Cognex (CGNX) shares are planned for sale under this Form 144?

The filing states that 177,052 Cognex common shares are planned for sale. These shares are to be sold through Fidelity Brokerage Services on NASDAQ, with an aggregate market value listed as $10,300,974.15 in the disclosure.

What is the aggregate market value of Cognex shares in this Form 144?

The Form 144 reports an aggregate market value of $10,300,974.15 for the 177,052 Cognex common shares. This figure reflects the total value of the proposed sale as of the pricing used in the notice to the SEC.

When are the Cognex (CGNX) shares expected to be sold according to the filing?

The notice lists an approximate sale date of February 12, 2026 for the Cognex common shares. This date reflects when the selling shareholder expects to begin sales, subject to market conditions and Rule 144 requirements.

How were the Cognex shares in this Form 144 acquired?

The securities come from option grants dated February 21, 2017 and February 20, 2024. The filing shows the common shares were acquired on February 12, 2026 from the issuer for cash upon exercise of those stock options.

How many Cognex shares are outstanding in this Form 144 disclosure?

The document states that 165,707,920 Cognex common shares are outstanding. This number provides context for the proposed sale amount, indicating the total shares of this class currently issued by the company.